Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Investors in Stevanato Group S.p.A. (NYSE:STVN) had a good week, as its shares rose 6.1% to close at US$18.03 following the release of its first-quarter results. It looks like a credible result overall - although revenues of €274m were in line with what the analysts predicted, Stevanato Group surprised by delivering a statutory profit of €0.10 per share, a notable 12% above expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.NYSE:STVN Earnings and Revenue Growth May 9th 2026
After the latest results, the nine analysts covering Stevanato Group are now predicting revenues of €1.28b in 2026. If met, this would reflect an okay 6.0% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to swell 10% to €0.57. Before this earnings report, the analysts had been forecasting revenues of €1.28b and earnings per share (EPS) of €0.56 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
View our latest analysis for Stevanato Group
There were no changes to revenue or earnings estimates or the price target of US$24.81, suggesting that the company has met expectations in its recent result. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Stevanato Group analyst has a price target of US$32.00 per share, while the most pessimistic values it at US$17.50. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Stevanato Group shareholders.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The period to the end of 2026 brings more of the same, according to the analysts, with revenue forecast to display 8.1% growth on an annualised basis. That is in line with its 9.0% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 6.5% per year. So it's pretty clear that Stevanato Group is forecast to grow substantially faster than its industry.
Story Continues
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that in mind, we wouldn't be too quick to come to a conclusion on Stevanato Group. Long-term earnings power is much more important than next year's profits. We have forecasts for Stevanato Group going out to 2028, and you can see them free on our platform here.
You can also view our analysis of Stevanato Group's balance sheet, and whether we think Stevanato Group is carrying too much debt, for free on our platform here.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
View Comments
Google